000 | 01648 a2200433 4500 | ||
---|---|---|---|
005 | 20250516224436.0 | ||
264 | 0 | _c20141111 | |
008 | 201411s 0 0 eng d | ||
022 | _a1872-7980 | ||
024 | 7 |
_a10.1016/j.canlet.2014.07.031 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aDuan, Lei | |
245 | 0 | 0 |
_aCritical roles for nitric oxide and ERK in the completion of prosurvival autophagy in 4OHTAM-treated estrogen receptor-positive breast cancer cells. _h[electronic resource] |
260 |
_bCancer letters _cOct 2014 |
||
300 |
_a290-300 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural | ||
650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
650 | 0 | 4 | _aAutophagy |
650 | 0 | 4 | _aBreast Neoplasms |
650 | 0 | 4 |
_aExtracellular Signal-Regulated MAP Kinases _xphysiology |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMAP Kinase Signaling System |
650 | 0 | 4 | _aMCF-7 Cells |
650 | 0 | 4 |
_aMicrotubule-Associated Proteins _xmetabolism |
650 | 0 | 4 |
_aNitric Oxide _xphysiology |
650 | 0 | 4 |
_aNitric Oxide Synthase Type II _xmetabolism |
650 | 0 | 4 |
_aNitric Oxide Synthase Type III _xmetabolism |
650 | 0 | 4 |
_aOxygen _xmetabolism |
650 | 0 | 4 |
_aPhagosomes _xmetabolism |
650 | 0 | 4 | _aProtein Processing, Post-Translational |
650 | 0 | 4 |
_aReceptors, Estrogen _xmetabolism |
650 | 0 | 4 |
_aTamoxifen _xanalogs & derivatives |
700 | 1 | _aDanzer, Brian | |
700 | 1 | _aLevenson, Victor V | |
700 | 1 | _aMaki, Carl G | |
773 | 0 |
_tCancer letters _gvol. 353 _gno. 2 _gp. 290-300 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.canlet.2014.07.031 _zAvailable from publisher's website |
999 |
_c24048381 _d24048381 |